Preview of 10 new studies on managing atopic dermatitis, including biologics, treatment barriers, and innovative care strategies for clinicians.
New research being presented at Revolutionizing Atopic Dermatitis (RAD) 2025 in Nashville, Tennessee, offers important updates for primary care physicians managing this common chronic condition. From long-term safety data on biologics like dupilumab and upadacitinib to new findings on atopic dermatitis (AD) during pregnancy, social determinants of disease, and treatment delays due to insurance barriers, this year's abstracts underscore the growing complexity of care for both pediatric and adult patients.
Above, find 10 medical abstract titles from RAD 2025 that are most relevant to frontline clinicians, including insights on comorbid asthma management, topical innovations, growth trends in children with AD, and real-world effectiveness data.
Bringing PPD Screening to the Forefront of Maternal Health: A Q&A with Joy Baker, MD
June 3rd 2025ACOG 2025: Joy Baker, MD, discusses the urgent need to prioritize postpartum depression screening, normalize mental health in prenatal care, and strengthen continuity between OB-GYN and primary care.